LEADER 01461nam 2200421 450 001 9910704521303321 005 20130509081234.0 035 $a(CKB)5470000002442495 035 $a(OCoLC)842230861 035 $a(EXLCZ)995470000002442495 100 $a20130509d2013 ua 0 101 0 $aeng 135 $aurmn||||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aEnd-stage renal disease $eCMS should improve design and strengthen monitoring of low-volume adjustment : report to congressional committees 210 1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2013. 215 $a1 online resource (ii, 26 pages) $ccolor illustrations 300 $aTitle from title screen (viewed Apr. 25, 2013). 300 $a"March 2013." 300 $a"GAO-13-287." 320 $aIncludes bibliographical references. 517 $aEnd-stage renal disease 606 $aMedicare$xEconomic aspects 606 $aMedicare$xClaims administration 606 $aHome hemodialysis$xCosts 606 $aChronic renal failure$xEconomic aspects 615 0$aMedicare$xEconomic aspects. 615 0$aMedicare$xClaims administration. 615 0$aHome hemodialysis$xCosts. 615 0$aChronic renal failure$xEconomic aspects. 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910704521303321 996 $aEnd-stage renal disease$93440710 997 $aUNINA